Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,781 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer.
Kono K, Mizukami Y, Daigo Y, Takano A, Masuda K, Yoshida K, Tsunoda T, Kawaguchi Y, Nakamura Y, Fujii H. Kono K, et al. Among authors: yoshida k. Cancer Sci. 2009 Aug;100(8):1502-9. doi: 10.1111/j.1349-7006.2009.01200.x. Epub 2009 May 14. Cancer Sci. 2009. PMID: 19459850 Free PMC article. Clinical Trial.
[New strategies in anti-tumor immunotherapy].
Iga-Murahashi M, Hijikata Y, Suehiro Y, Inoue H, Tanaka Y, Shimoda S, Marumoto T, Okazai T, Yoshida K, Tsunoda T, Tani K. Iga-Murahashi M, et al. Among authors: yoshida k. Rinsho Ketsueki. 2010 Nov;51(11):1654-60. Rinsho Ketsueki. 2010. PMID: 21157128 Review. Japanese. No abstract available.
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy.
Yoshioka H, Yamamoto S, Hanaoka H, Iida Y, Paudyal P, Higuchi T, Tominaga H, Oriuchi N, Nakagawa H, Shiba Y, Yoshida K, Osawa R, Katagiri T, Tsunoda T, Nakamura Y, Endo K. Yoshioka H, et al. Among authors: yoshida k. Cancer Immunol Immunother. 2012 Aug;61(8):1211-20. doi: 10.1007/s00262-011-1186-0. Epub 2012 Jan 6. Cancer Immunol Immunother. 2012. PMID: 22223257 Free PMC article.
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
Kono K, Iinuma H, Akutsu Y, Tanaka H, Hayashi N, Uchikado Y, Noguchi T, Fujii H, Okinaka K, Fukushima R, Matsubara H, Ohira M, Baba H, Natsugoe S, Kitano S, Takeda K, Yoshida K, Tsunoda T, Nakamura Y. Kono K, et al. Among authors: yoshida k. J Transl Med. 2012 Jul 9;10:141. doi: 10.1186/1479-5876-10-141. J Transl Med. 2012. PMID: 22776426 Free PMC article. Clinical Trial.
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer.
Masuzawa T, Fujiwara Y, Okada K, Nakamura A, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Osawa R, Takeda K, Yoshida K, Tsunoda T, Nakamura Y, Mori M, Doki Y. Masuzawa T, et al. Among authors: yoshida k. Int J Oncol. 2012 Oct;41(4):1297-304. doi: 10.3892/ijo.2012.1573. Epub 2012 Jul 25. Int J Oncol. 2012. PMID: 22842485 Clinical Trial.
11,781 results
You have reached the last available page of results. Please see the User Guide for more information.